Aflac (AFL)
(Delayed Data from NYSE)
$110.59 USD
+0.52 (0.47%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $110.59 0.00 (0.00%) 5:22 PM ET
1-Strong Buy of 5 1
D Value F Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$110.59 USD
+0.52 (0.47%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $110.59 0.00 (0.00%) 5:22 PM ET
1-Strong Buy of 5 1
D Value F Growth C Momentum F VGM
Zacks News
Aflac (AFL) Grows Product Menu Via New Dental & Vision Offers
by Zacks Equity Research
Aflac (AFL) introduces a dental and vision insurance package, thereby widening its product portfolio in the U.S. segment.
Reasons for Betting on Amerisafe (AMSF) to Boost Portfolio
by Zacks Equity Research
Amerisafe's (AMSF) presence in workers' compensation insurance and its disciplined underwriting abilities make the stock an attractive bet.
Is Aflac (AFL) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Unum (UNM) Enters Into $7.1B Reinsurance Deal With Global Atlantic
by Zacks Equity Research
Unum (UNM) inks a deal with Global Atlantic to reinsure its Closed Individual Disability Insurance Block business.
Aflac (AFL) Down 13% in 2020: Will It Bounce Back in 2021?
by Zacks Equity Research
A slew of initiatives recently taken by Aflac (AFL) should aid the stock in 2021 after suffering from COVID-led business loss in 2020.
Is Aflac (AFL) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why You Should Retain CNO Financial (CNO) in Your Portfolio
by Zacks Equity Research
Riding on technology and cost-curbing measures, CNO Financial (CNO) holds potential to reap benefits for investors.
Here's Why Investors Should Bet on Amerisafe (AMSF) Stock Now
by Zacks Equity Research
Amerisafe (AMSF) remains well-poised for growth on the back of its disciplined approach to underwriting and prudent capital management strategies.
Why Is Aflac (AFL) Up 33.6% Since Last Earnings Report?
by Zacks Equity Research
Aflac (AFL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Should You Add Hartford Financial (HIG) to Your Portfolio?
by Zacks Equity Research
Backed by its strategic measures and a sturdy capital structure, Hartford Financial (HIG) holds promises to reap benefits for investors.
Is Aflac (AFL) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Aflac (AFL) Rewards Shareholders With 17.9% Dividend Hike
by Zacks Equity Research
Aflac's (AFL) recent dividend hike reflects strong financial position and constant efforts to enhance shareholders' value.
Aflac (AFL) Rides on U.S. Business Growth, Cost-Control Moves
by Zacks Equity Research
Initiatives to grow its U.S. segment, strong capital position and cost-saving efforts poise Aflac (AFL) for growth.
What Makes Aflac (AFL) a New Buy Stock
by Zacks Equity Research
Aflac (AFL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Should Value Investors Buy Aflac (AFL) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Aflac's (AFL) Q3 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Aflac's (AFL) third-quarter results reflect higher revenues, partly offset by high costs.
Aflac (AFL) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Aflac (AFL) delivered earnings and revenue surprises of 24.11% and 3.40%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Cboe Global (CBOE) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
CBOE Global's (CBOE) Q3 results are expected to reflect higher market data fees and access fees, partially offset by lower transactions fees and regulatory fees.
CME Group (CME) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
CME Group's (CME) third-quarter performance is likely to have benefited from clearing and transaction fees, market data and information services revenues and derivative product lines.
Will Aflac (AFL) Maintain its Beat Streak in Q3 Earnings?
by Zacks Equity Research
Aflac's (AFL) Aflac Japan and U.S. segments are expected to have seen strained revenues in Q3 due to COVID-19-led business disruption.
What's in Store for Unum Group (UNM) This Earnings Season?
by Zacks Equity Research
Unum Group (UNM) third-quarter results are likely to reflect lower premium income and weak investment income due to the COVID-19 pandemic.
Aflac (AFL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Aflac (AFL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Aflac (AFL) Could Beat Earnings Estimates Again
by Zacks Equity Research
Aflac (AFL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
7 Insurers Poised to Beat Estimates This Earnings Season
by Tanuka De
Better pricing and underwriting practice, product repositioning and sturdy capital will help these insurers outperform Q3 earnings estimates.
Aflac (AFL) Drops 28% YTD: Will It Make a Comeback Soon?
by Zacks Equity Research
Aflac (AFL) struggles with a weak operating landscape and business inconsistencies in the Japan segment.